Author

Katharina Schindowski

Observed names: K SCHINDOWSKI, K Schindowski, K. Schindowski, K. Schindowski, Katharina Schindowski Zimmermann, Katharina Schindowski-Zimmermann, Schindowski, Katharina

Institution: University of Applied Sciences Biberach

Observed institutions: Goethe University Frankfurt, Inserm, German Cancer Research Center, Universität Ulm, University of Applied Sciences Biberach, Heidelberg University, Université de Lille, Centre de Recherche Jean Pierre Aubert

ORCID: 0000-0003-2514-1654

Observed ORCID: 0000-0003-2514-1654

OpenAlex ID: A5047124498

Tailoring Formulations for Intranasal Nose-to-Brain Delivery: A Review on Architecture, Physico-Chemical Characteristics and Mucociliary Clearance of the Nasal Olfactory Mucosa

2018 · Stella Gänger, Katharina Schindowski · Pharmaceutics · 472

PDF

Alzheimer's Disease-Like Tau Neuropathology Leads to Memory Deficits and Loss of Functional Synapses in a Novel Mutated Tau Transgenic Mouse without Any Motor Deficits

2006 · Katharina Schindowski, Alexis Bretteville, et al. · American Journal Of Pathology · 438

PDF

Neurotrophic factors in Alzheimer’s disease: role of axonal transport

2008 · K. Schindowski, K. Belarbi, et al. · Genes Brain & Behavior · 336

PDF

Early Axonopathy Preceding Neurofibrillary Tangles in Mutant Tau Transgenic Mice

2007 · Karelle Leroy, Alexis Bretteville, et al. · American Journal Of Pathology · 149

PDF

Effects of EGb 761® Ginkgo biloba Extract on Mitochondrial Function and Oxidative Stress

2003 · A. Eckert, U. Keil, et al. · Pharmacopsychiatry · 134

Fc-Engineered Therapeutic Antibodies: Recent Advances and Future Directions

2023 · Dalia T. Abdeldaim, Katharina Schindowski · Pharmaceutics · 118

PDF

2001 · K. Schindowski, S. Leutner, et al. · Journal of Neural Transmission · 108

Passive anti-amyloid immunotherapy in Alzheimer's disease: What are the most promising targets?

2013 · Jens Moreth, Chrystelle Mavoungou, et al. · Immunity & Ageing · 103

PDF

Improved In Vitro Model for Intranasal Mucosal Drug Delivery: Primary Olfactory and Respiratory Epithelial Cells Compared with the Permanent Nasal Cell Line RPMI 2650

2019 · Simone Ladel, Patrick Schlossbauer, et al. · Pharmaceutics · 96

PDF

p25/Cdk5-mediated retinoblastoma phosphorylation is an early event in neuronal cell death

2005 · Malika Hamdane, Alexis Bretteville, et al. · Journal of Cell Science · 95

Enhanced apoptosis, oxidative stress and mitochondrial dysfunction in lymphocytes as potential biomarkers for Alzheimer’s disease

2007 · K. Leuner, J. Pantel, et al. · Springer eBooks · 74

2002 · Katharina Schindowski, Lutz Fröhlich, et al. · Mechanisms of Ageing and Development · 73

PDF

Regulation of GDF-15, a distant TGF-β superfamily member, in a mouse model of cerebral ischemia

2010 · Katharina Schindowski, Oliver von Bohlen und Halbach, et al. · Cell and Tissue Research · 72

PDF

2000 · K Schindowski · Neurobiology of Aging · 72

Early Tau Pathology Involving the Septo-Hippocampal Pathway in a Tau Transgenic Model: Relevance to Alzheimers Disease

2009 · Karim Belarbi, Katharina Schindowski, et al. · Current Alzheimer Research · 61

Reduced antioxidant enzyme activity in brains of mice transgenic for human presenilin-1 with single or multiple mutations

2000 · Silke Leutner, Christian Czech, et al. · Neuroscience Letters · 60

A comprehensive screening platform for aerosolizable protein formulations for intranasal and pulmonary drug delivery

2017 · Martina Röhm, Stefan Carle, et al. · International Journal of Pharmaceutics · 57

PDF

Increased T-cell Reactivity and Elevated Levels of CD8+ Memory T-cells in Alzheimer’s Disease-patients and T-cell Hyporeactivity in an Alzheimer’s Disease-mouse Model: Implications for Immunotherapy

2007 · Katharina Schindowski, Anne Eckert, et al. · NeuroMolecular Medicine · 55

Alzheimer's Disease-like Alterations in Peripheral Cells from Presenilin-1 Transgenic Mice

2001 · Anne Eckert, Katharina Schindowski, et al. · Neurobiology of Disease · 55

PDF

Nano-in-Micro-Particles Consisting of PLGA Nanoparticles Embedded in Chitosan Microparticles via Spray-Drying Enhances Their Uptake in the Olfactory Mucosa

2021 · Lena Marie Spindler, Andreas Feuerhake, et al. · Frontiers in Pharmacology · 54

Loss of Medial Septum Cholinergic Neurons in THY-Tau22 Mouse Model: What Links with tau Pathology?

2011 · K. Belarbi, S. Burnouf, et al. · Current Alzheimer Research · 53

Neurogenesis and cell cycle‐reactivated neuronal death during pathogenic tau aggregation

2008 · K. Schindowski, K. Belarbi, et al. · Genes Brain & Behavior · 52

PDF

Enhanced ROS-Generation in Lymphocytes from Alzheimer’s Patients

2005 · S. Leutner, K. Schindowski, et al. · Pharmacopsychiatry · 51

Enlarged infarct volume and loss of BDNF mRNA induction following brain ischemia in mice lacking FGF-2

2004 · I KIPRIANOVA, K SCHINDOWSKI, et al. · Experimental Neurology · 51

Selective CNS Targeting and Distribution with a Refined Region-Specific Intranasal Delivery Technique via the Olfactory Mucosa

2021 · Frank Maigler, Simone Ladel, et al. · Pharmaceutics · 43

PDF

Works count: 78

Citation count: 3,381

H-index: 31

I10-index: 38